NCT04667026 Observational Study on Patients With HIV/AIDS(OSPWH)
| NCT ID | NCT04667026 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangzhou 8th People's Hospital |
| Condition | HIV Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2009-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2009-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To establish a follow-up cohort of antiretroviral therapy(ART) for patients with HIV/AIDS, to observe the ART efficacy and adverse reactions, complications in the process of ART, as well as mortality and causes of death, so as to provide basis for further improving ART efficacy and quality of life of the patients.
Eligibility Criteria
Inclusion Criteria: * Patients has a history of diagnosis of HIV. * Receiving antiretroviral therapy. * Good treatment compliance. Exclusion Criteria: * Aged less than 14 years of old.
Contact & Investigator
Linghua Li, MD,PhD
✉ llheliza@126.comLing-Hua Li, doctor
PRINCIPAL INVESTIGATOR
Guangzhou Eighth People's Hospital
Frequently Asked Questions
Who can join the NCT04667026 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04667026 currently recruiting?
Yes, NCT04667026 is actively recruiting participants. Contact the research team at llheliza@126.com for enrollment information.
Where is the NCT04667026 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT04667026 clinical trial?
NCT04667026 is sponsored by Guangzhou 8th People's Hospital. The principal investigator is Ling-Hua Li, doctor at Guangzhou Eighth People's Hospital. The trial plans to enroll 15,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.